CEO
Richard Toselli
Employees
19
Industry
Surgical and Medical Instrument Manufacturing
about invivo therapeutics invivo therapeutics holdings corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries. the company was founded in 2005 with proprietary technology co-invented by robert langer, sc.d., professor at massachusetts institute of technology, and joseph p. vacanti, m.d., who then was at boston children’s hospital and who now is affiliated with massachusetts general hospital. in 2011, the company earned the david s. apple award from the american spinal injury association for its outstanding contribution to spinal cord injury medicine. in 2015, the company’s investigational neuro-spinal scaffold received the 2015 becker’s healthcare spine device award. the publicly-traded company is headquartered in cambridge, ma. for more details, visit www.invivotherapeutics.com. about the neuro-spinal scaffold™ following acute spinal cord injury, surgical implantation of the biodegradable neuro-spinal scaffold wi
Loading...
Open
0.41
Mkt cap
996K
Volume
1.6M
High
0.41
P/E Ratio
-0.10
52-wk high
2.40
Low
0.30
Div yield
N/A
52-wk low
0.22
Portfolio Pulse from Benzinga Insights
February 12, 2024 | 9:31 pm
Portfolio Pulse from Avi Kapoor
February 12, 2024 | 6:07 pm
Portfolio Pulse from Benzinga Insights
February 12, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Insights
February 08, 2024 | 1:06 pm
Portfolio Pulse from Benzinga Newsdesk
February 06, 2024 | 8:29 pm
Portfolio Pulse from Avi Kapoor
February 06, 2024 | 6:17 pm
Portfolio Pulse from Benzinga Insights
February 06, 2024 | 5:31 pm
Portfolio Pulse from Benzinga Newsdesk
February 06, 2024 | 5:07 pm
Portfolio Pulse from Benzinga Newsdesk
February 06, 2024 | 5:05 pm
Portfolio Pulse from Benzinga Newsdesk
February 06, 2024 | 4:45 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.